Detalhe da pesquisa
1.
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Lancet
; 403(10422): 171-182, 2024 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104577
2.
Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center.
Int J Cancer
; 149(1): 139-148, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586179
3.
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.
Cancer Immunol Res
; 12(3): 308-321, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108398
4.
Plasma Circulating Tumor DNA to Assist in the Diagnose of Unknown Primary Malignancy Underlying Choroidal Metastases.
Retin Cases Brief Rep
; 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113252
5.
Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer.
JCO Precis Oncol
; 7: e2300030, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384866
6.
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Nat Med
; 29(12): 3077-3089, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620627
7.
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
Front Oncol
; 13: 1253629, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795442
8.
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis.
Int J Radiat Oncol Biol Phys
; 116(5): 1091-1099, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889516
9.
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
Nat Med
; 28(11): 2353-2363, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357680
10.
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.
J Clin Oncol
; 39(1): 30-37, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822275
11.
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers.
Clin Cancer Res
; 26(8): 1796-1802, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919132
12.
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer.
Lung Cancer
; 122: 67-71, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30032847
13.
Exceptional Response of a Large and Symptomatic EGFR-Mutant Brain Metastasis to Osimertinib: Case Report and Review of the Literature.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34095710
14.
Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers.
Lung Cancer
; 99: 53-6, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565914
15.
Patient Death Debriefing Sessions to Support Residents' Emotional Reactions to Patient Deaths.
J Grad Med Educ
; 7(3): 430-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26457151
16.
Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas.
J Thorac Oncol
; 10(12): 1713-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26334752
17.
Personalized therapy for lung cancer.
Chest
; 146(6): 1649-1657, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25451351
18.
Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers.
JCO Precis Oncol
; 22018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30957057
19.
Spatial distance and mental construal of social events.
Psychol Sci
; 17(4): 278-82, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16623682